移植评估评定量表可预测异基因造血干细胞移植后的总生存
研究对2003至2017年在本中心接受首次异基因造血干细胞移植的556例连续患者,在移植前由心理医师前瞻性评估TERS评分并分为低、中、高风险组。结果显示,TERS高风险组住院时间更长,中/高风险评分与较差OS和较高NRM相关;在疾病风险指数低/中危亚组中,中/高风险TERS仍预测更差OS、更差DFS和更高NRM。
要点
- TERS高风险组移植后180天和1年住院时间显著长于低风险组(16 vs 13天,21 vs 16天)。
- 多因素分析中,中/高风险TERS评分预测较差OS、相似DFS和更高NRM。
- 在疾病风险指数低/中危患者中,TERS中/高风险仍预测更差OS、更差DFS和更高NRM。
核心结论
- TERS评估的心理社会因素是异基因造血干细胞移植后发病和死亡的强预测因素,尤其在疾病风险低/中危患者中。
研究设计与样本
- 前瞻性队列研究,纳入2003至2017年在本中心接受首次异基因造血干细胞移植的556例连续患者。
- 移植前由心理医师前瞻性评估TERS评分,并按评分将患者分为低、中、高风险组。
主要发现
- TERS高风险组移植后180天和1年住院时间显著长于低风险组(16 vs 13天,P = .05;21 vs 16天,P = .02)。
- 低、中、高风险TERS组3年OS分别为73%、60%、65%,DFS分别为63%、55%、60%,NRM分别为11%、20%、17%,复发率分别为26%、25%、23%。
- 多因素分析中,中/高风险TERS评分较低风险预测更差OS、相似DFS和更高NRM。
- 在疾病风险指数低/中危亚组中,中/高风险TERS评分较低风险预测显著更差OS、更差DFS、更高NRM和相似复发率。
临床怎么用
- 移植前可采用TERS评分识别心理社会高风险患者,以预判住院时间延长和生存不良风险。
- 对疾病风险指数低/中危但TERS中/高风险的患者,应加强移植后监测与支持。
局限性
- 研究为单中心前瞻性队列,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To evaluate the impact of psychosocial risks on post-hematopoietic stem cell transplantation (HSCT) outcomes, we prospectively conducted psychosocial assessment of 556 consecutive allogeneic HSCT patients who received their first allogeneic transplant at our center between 2003 and 2017. The Transplant Evaluation Rating Scale (TERS) score was prospectively assessed by a psychologist before transplantation, and patients were categorized as low, intermediate, or high risk based on their TERS score. Patients in the high-risk TERS group had significantly longer hospital stays during the first 180 days and 1 year post-allogeneic HSCT compared with the low-risk group (16 vs 13 and 21 vs 16 days; P = .05 and .02, respectively). The survival estimates for low-, intermediate-, and high-risk TERS groups at 3 year were as follows: overall survival (OS), 73%, 60%, and 65%; disease-free survival (DFS), 63%, 55%, and 60%; nonrelapse mortality (NRM), 11%, 20%, and 17%; and relapse, 26%, 25%, and 23%, respectively. In a multivariable analysis, intermediate- and high-risk TERS scores predicted for inferior OS, similar DFS, and higher NRM compared with low-risk TERS score. In a subset analysis of patients with low/intermediate risk per Disease Risk Index, multivariable analysis showed that high- and intermediate-risk TERS scores predicted for significantly worse OS, worse DFS, higher NRM, and similar relapse rates compared with low-risk TERS score. Our findings show that psychosocial factors as measured by TERS score are strong predictors of morbidity and mortality after HSCT among patients with low/intermediate disease risk.
引用
- Solh MM, Speckhart D, Solomon SR, et al. The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation. Blood Adv. 2020. PMID: 33022065. doi:10.1182/bloodadvances.2020002204
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。